Patent details

Basic Information

Publication number:

EP1696900

PCT Application Number:

PCT/US/2004/042283

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP048144620

PCT Publication Number:

WO/2005/058303

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF TREPROSTINIL TO TREAT ISCHEMIC LESIONS

French Title of Invention:

UTILISATION DU TREPROSTINIL DANS LE TRAITEMENT DES LESIONS ISCHEMIQUES

German Title of Invention:

VERWENDUNG VON TREPROSTINIL ZUR BEHANDLUNG VON ISCHÄMISCHEN LÄSIONEN

SPC Number:

Dates

Filing date:

16/12/2004

Grant date:

14/07/2010

EP Publication Date:

14/07/2010

PCT Publication Date:

30/06/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/09/2006

EP B1 Publication Date:

14/07/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/12/2010

Expiration date:

16/12/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/12/2004

 

 

Name:

United Therapeutics Corporation

Address:

1040 Spring Street Silver Spring, Maryland 20910, United States (US)

Inventor

1

Name:

JEFFS Roger A., c/o United Therapeutics Corp.

Address:

United States (US)

2

Name:

BRONSTEIN Kathryn

Address:

United States (US)

3

Name:

ROSCIGNO Robert, c/o United Therapeutics Corp.

Address:

United States (US)

4

Name:

STROOTMAN Deborah, c/o United Therapeutics

Address:

United States (US)

5

Name:

WADE Michael, c/o United Therapeutics Corp.

Address:

United States (US)

Priority

Priority Number:

529622 P

Priority Date:

16/12/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/191;

Filing date	Document type	Number of pages